On the other hand, with an increase in this website the volume of bleeding and obstetrical disseminated intravascular coagulation (DIC) scores, packed red blood cells and

fresh frozen plasma (FFP) were administrated. As the fibrinogen level decreases early in atonic bleeding, the early administration of FFP may be important as an initial approach to treat the disease. In study 2, amniotic fluid embolism was classified into two types: that involving cardiopulmonary collapse; and that following DIC. Pathologically, the former type is conventional, in which fetal and amniotic fluid components are observed in pulmonary blood vessels. The pathological characteristics of the latter type include uterine atony, and selleck chemicals the presence of fetal and amniotic fluid components in uterine blood vessels. In this type, fetal and amniotic fluid components are occasionally absent in the lungs.

Among cases of clinical amniotic fluid embolism without fetal and amniotic fluid components in the lungs (or pulmonary examination findings are unavailable in life-saving settings), those involving uterine atony in the presence of fetal and amniotic fluid components in uterine blood vessels may be called uterus-type amniotic fluid embolism. The authors have no conflict of interest to declare. “
“To investigate the impact of antenatal exposure to a single course or repeated courses Olopatadine of dexamethasone (DEX) on neonatal anthropometrics, placental morphometry and potential effect on maternal plasma levels and placental expression of vascular endothelial growth factor (VEGF). Pregnant women between 27 and 32 weeks of gestation who delivered between 28 and 40 weeks and received a single course (n = 38) or repeated courses (n = 33) of DEX were compared to gestational age-matched controls (n = 30). Maternal blood samples were obtained, and placental biopsy was taken. Area percent

of VEGF immunostaining and villous capillarization index were evaluated using image analysis. Infants exposed to repeated courses of DEX were significantly associated with decreased birthweight, body length, head circumference and placental weight compared with controls (P = 0.011, P < 0.001, P = 0.004, P < 0.001, respectively) and with the group that received a single course of DEX (P = 0.021, P = 0.020, P = 0.049, P = 0.010, respectively). There was a significant decrease in maternal VEGF plasma levels and percentage of VEGF immunostained area after repeated courses of DEX compared with controls (P < 0.001 and P = 0.001, respectively) or a single course (P = 0.028 and P = 0.002, respectively). Notably, repeated courses of DEX impaired normal increase in villous capillarization index compared with controls or a single course (P = 0.001 and P = 0.041, respectively).